CardieX Limited has acquired all the assets of Blumio, Inc., a Silicon Valley based developer of advanced algorithms and technology for cardiovascular sensors, signifying the company’s continued investment in cardiovascular health monitoring technologies. Blumio’s technology has the potential to significantly increase clinical performance for CardieX’s ecosystem of heart health monitoring solutions.

Financial terms of the transaction were not disclosed.

Blumio has been leading the charge in developing wearable sensor technologies that can capture a cardiovascular signal without necessitating the use of pulse pressure. As a result of the prior 3-year collaboration between Blumio and CardieX, the companies have already demonstrated Blumio’s sensor technology to be compatible with ATCOR’s patented SphygmoCor® arterial health technology.

Blumio brings a suite of capabilities in wearable sensor development, signal processing, and big data analytics expertise that will benefit both of our ATCOR and CONNEQT brands, especially in relation to the ongoing development activities surrounding our CONNEQT Band. This acquisition is a natural extension of our core solutions that provide a comprehensive ecosystem of unique health and wellness features focused on heart health.

Craig Cooper, CardieX Group CEO

Blumio has also developed a suite of data analytics and visualization tools used to uncover insights in clinical data that significantly contribute to CardieX’s current wearable development efforts. These tools will enhance CardieX’s “Arty™ Heart Health Analytics Platform” to proactively monitor, alert, and provide actionable health insights from CardieX’s CONNEQT Pulse and CONNEQT Band devices – thereby enabling physicians and patients alike to make more informed healthcare decisions.

en_GBEnglish (UK)